Practice
Featured experience
Incora emerges from chapter 11
We advised an ad hoc group of secured noteholders in connection with Incora’s chapter 11 proceedings
Venture Global $1.75 billion IPO
We advised Venture Global on its IPO and NYSE listing
Interactive Brokers claims for domestic production activities deductions
We are representing Interactive Brokers
Advice to multiple companies on potential tax refunds under the Varian ruling
We are representing clients in refund claims
Bristol Myers Squibb $13 billion notes offering
The investment-grade offering comprised nine tranches
Intel $2.55 billion senior notes offering
The senior notes are due 2031, 2034 and 2054
REV Group $289.9 million secondary offering
We advised REV Group on its SEC-registered secondary stock offering
Cardinal Health $1.15 billion notes offering
The investment-grade notes are due 2029 and 2034
Kyndryl $500 million senior notes offering
We advised Kyndryl on the SEC-registered notes
Delinea acquisition of Fastpath Solutions
We are advising Delinea on the acquisition
Prime Medicine $161 million stock and pre-funded warrants offering
The common stock is listed on the Nasdaq Global Market
Gates Industrial $246 million secondary offering
The offering involved 20.125 million ordinary shares
Amer Sports $800 million senior secured notes offering
We advised Amer Sports on the high-yield notes offering
Marsh McLennan $1 billion senior notes offering
We advised Marsh McLennan on its investment-grade notes offering